The annual cost of treating adult cases of diabetes in the United States nearly doubled between 2001 and 2007, according to a study published Monday that questioned the efficacy of new, more expensive drugs.
The increase was due to a rise in the number of sufferers but also higher use of more costly treatments, said the study from researchers at the Stanford University School of Medicine and the University of Chicago.
Diabetes - Self-Monitoring of Blood Glucose (SMBG)
Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements in the management of Diabetes.
Advertisement
"It's important to recognize how expensive treatment for diabetes has become," said Randall Stafford, associate professor of medicine at the Stanford Prevention Research Center and senior author of the study.
"This near-doubling of diabetes costs may partly reflect better care, but we need to step back and examine the value of newer and more costly medications that may be overused."
The cost of diabetes treatments rose from 6.7 billion dollars in 2001 to 12.5 billion dollars in 2007.
In 2000, 4.0 percent of the US population had diabetes. By 2050, the percentage is expected to increase to 7.0 percent, the study said.
Source: AFP
SRM/SK
The cost of diabetes treatments rose from 6.7 billion dollars in 2001 to 12.5 billion dollars in 2007.
In 2000, 4.0 percent of the US population had diabetes. By 2050, the percentage is expected to increase to 7.0 percent, the study said.
Source: AFP
SRM/SK
Insulin Delivery Devices
Insulin delivery devices have evolved drastically since their invention in 1922. They are all aimed to provide insulin to the patients with minimal discomfort.
Advertisement
 Blood Sugar ChartThe blood sugar chart gives you the fasting glucose values and glucose tolerance test values for normal people and people with early diabetes and established diabetes. Also use the calculator to find out if you have diabetes. | Advertisement
|
Advertisement
Recommended Readings
Latest Diabetes News
Recent study underscores tirzepatide's supremacy over semaglutide in regulating blood sugar and achieving weight loss.
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Late sleepers and late risers may both have a higher risk of developing diabetes.
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
